The Business Times
business-time-50

Sinopharm

Consumer & Healthcare

Sinopharm’s China TCM buyout bid lapses without regulatory nods

2024-10-18T14:45:00.000Z
Sinopharm, the parent of China-TCM, already holds a 32.46 per cent stake in China-TCM and has offered to pay HK$4.6 (S$0.79) per share in cash to buyout the drugmaker.
Companies & Markets

Sinopharm offers to take China-TCM private in nearly US$3 billion deal

2024-02-21T13:41:19.000Z
Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
View More